Abstract
Obesity, hypertension (HTN) and type 2 diabetes (T2D) are among the multifactorial disorders that occur at higher prevalence in a population. This study aims to assess the health-related quality of life (HRQoL) of patients with obesity, HTN and T2D individually and in the form of multimorbidity. A questionnaire-based cross-sectional study was conducted among the patients in 15 private clinics of Punjab, Pakistan. A stratified random sampling technique was used to collect the data from patients with obesity, HTN and T2D or their comorbidity. A total of 1350 patients responded by completing the questionnaire. The HRQoL of these patients was assessed using the EQ-5D-5L questionnaire (a standardized instrument for measuring generic health status). Statistical analysis was performed using chi-square test, Mann-Whitney U test, and Kruskal-Wallis test. Multivariate linear regression model was used to model the visual analogue scale (VAS) score. In total, 15% of patients had combined obesity, HTN and T2D; 16.5% had HTN and T2D; 13.5% had obesity and HTN and 12.8% had obesity and T2D. Only 15.8% of patients had obesity, 14.3% had HTN, and 12% had T2D. Mann Whitney-U test gave the statistically significant (p = <0.001) HRQoL VAS score55.1 (±23.2) of patients with the obesity. HRQoL VAS scores of patients with obesity were found to be higher when compared to patients with both T2D 49.8 (±15.4) and HTN 48.2 (±21). Diagnosis of one, two and three diseases showed significant results in VAS with all variables including gender (p = 0.004), educational level (p = <0.001), marital status (p<0.001), residence (p = <0.001), financial situation (p = <0.001) and monthly income (p = <0.001). The most frequently observed extremely problematic dimension was anxiety/ depression (47%) and the self-care (10%) was the least affected. Patient HRQoL is decreased by T2D, HTN, and obesity. The impact of these diseases coexisting is more detrimental to HRQoL.
Publisher
Public Library of Science (PLoS)
Reference28 articles.
1. Incidence of type 2 diabetes, hypertension, and dyslipidemia in metabolically healthy obese and non-obese;M. Fingeret;Nutrition, Metabolism and Cardiovascular Diseases,2018
2. Prevalence of Hypertension, ObesityDiabetes, and Metabolic Syndrome in Nepal;S.K. Sharma;International Journal of Hypertension,2011
3. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis;D.P. Guh;BMC public health,2009
4. Prevalence of hypertension and obesity in patients with type 2 diabetes mellitus in observational studies: a systematic literature review;A.D. Colosia;Diabetes, metabolic syndrome and obesity: targets and therapy,,2013
5. Insulin Resistance and Other Mechanisms of Obesity Hypertension.;V. Thaker;Pediatric Hypertension,2023